PARP Inhibition in Prostate Cancer With Homologous Recombination Repair Alterations Literature searches were conducted in MEDLINE (via PubMed) and EMBASE to identify studies published between January ...
"We are excited to make the HER1 and HER3 assays available for clinical development use," said William Young, president and CEO of Monogram Biosciences. "Our first VeraTag product, HERmark, is already ...
Precision medicine is driven by advances in omics technologies that facilitate identification of mutations and the presence or absence of certain molecular targets, which, in turn, enables streamlined ...
DAVIS, Calif.--(BUSINESS WIRE)--Gold Standard Diagnostics Inc. today announced the EUA submission of a Multiplex Real-Time, reverse-transcriptase polymerase chain reaction (RT-PCR) assay for the ...
In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...
Spanning the Gap between Synthetic Lipid Chemisty and Signal Transduction Biology Many scientists are familiar with lipids as hydrophobic molecules that form biological cell membranes. However, ...
The three high-sensitivity cardiac troponin (hs-cTn) assays currently available in the United States often disagree when it comes to standard analytical benchmarks, which could have an impact on how ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced the initiation of a large-scale, multi-center prospective clinical study to validate its circulating tumor DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback